Healthcare Services Japan

Japan Metabolic Surgery Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Japan Metabolic Surgery Market Industry Trends and Forecast to 2034: Segmented by (Procedure, Approach, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Japan · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $665.2 Mn Placeholder estimate
Estimate 2025 $713.7 Mn 7% of the global market
Projected 2034 $1.35 Bn 88.5% Adds $631.9 Mn over 9 forecast years
CAGR 2025–2034 7.3% Faster than 20% of 109 Healthcare Services markets here
Key players 5
  • Japan is 6.99% of the global market.
  • In APAC, the largest is China at $895.1 Mn.
  • Fastest growing: India at 9.6% a year.
  • Japan ranks 2nd of 10 by size in APAC.

Market size projection

Japan

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$631.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Metabolic Surgery Market market size by year, Japan
YearMarket sizeChange that yearSince 2025
2024 (estimate) $665.2 Mn — —
2025 (base) $713.7 Mn +$48.6 Mn —
2026 (forecast) $765.8 Mn +$52.1 Mn +7.3%
2027 (forecast) $821.7 Mn +$55.9 Mn +15.1%
2028 (forecast) $881.7 Mn +$60.0 Mn +23.5%
2029 (forecast) $946.1 Mn +$64.4 Mn +32.6%
2030 (forecast) $1.02 Bn +$69.1 Mn +42.2%
2031 (forecast) $1.09 Bn +$74.1 Mn +52.6%
2032 (forecast) $1.17 Bn +$79.5 Mn +63.8%
2033 (forecast) $1.25 Bn +$85.3 Mn +75.7%
2034 (forecast) $1.35 Bn +$91.5 Mn +88.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Japan Metabolic Surgery Market Analysis at a glance
Market size, 2025$713.7 Mn placeholder estimate
Forecast, 2034$1.35 Bn placeholder estimate
Growth (CAGR), 2025–20347.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProcedure, approach and end user (see all)
Key playersMedtronic, Johnson & Johnson, Intuitive Surgical, Olympus Corporation, Teleflex Inc (see all)
Active clinical trials12 in JapanSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Japan. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Japan Metabolic Surgery Market Analysis Executive Summary

Metabolic surgery uses weight-loss operations to treat type 2 diabetes and other metabolic diseases, not only to reduce weight.

Key segments of the metabolic Surgery market include procedure (Sleeve Gastrectomy, Roux-en-Y Gastric Bypass and Duodenal Switch) and approach (Laparoscopic, Robotic-Assisted and Endoscopic).

Bar chart: Japan Metabolic Surgery market size, 2024–2034, placeholder estimates. $665.2 Mn in 2024, $713.7 Mn in 2025 and $1.35 Bn in 2034, 7.3% CAGR.
Japan Metabolic Surgery market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Japan Metabolic Surgery Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the metabolic Surgery market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the metabolic Surgery market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the metabolic Surgery market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Metabolic Surgery Market in Japan

The metabolic Surgery market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Metabolic Surgery Market in Japan

Metabolic Surgery in Japan: payment and research

Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices).⁠[1] ClinicalTrials.gov lists 12 studies on Metabolic Surgery that are recruiting, active or about to start in Japan.⁠[2] Obesity (adults): 5.9% of adults in 2024, the latest WHO figure for Japan.⁠[3]

[1] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[2] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Japan. Retrieved 12 Nov 2026.

[3] WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 22 Nov 2026.

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how metabolic Surgery services are delivered and paid for in Japan. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Metabolic Surgery right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 22 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Metabolic Surgery in context

Japan compared

  • Obesity (adults): 5.9% of adults (2024). World: 16.2% of adults (2024). 15th highest of the 17 countries we cover in APAC.[1]
  • Health spending per person: 3,638 US$ per person (2023). World: 1,317 US$ per person (2023). 4th highest of the 17 countries we cover in APAC.[2]
  • Doctors: 2.65 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 5th highest of the 17 countries we cover in APAC.[3]

[1] WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 21 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.

Free data on this topic

Inside Japan

Quick answers

Frequently asked questions

How big is the Metabolic Surgery market in Japan?
Placeholder estimate: about $713.7 Mn in 2025, rising to about $1.35 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Metabolic Surgery market in Japan growing?
Placeholder estimate: about 7.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Metabolic Surgery market report cover?
The report splits the market by procedure (Sleeve Gastrectomy, Roux-en-Y Gastric Bypass, Duodenal Switch, Revisional Surgery), approach (Laparoscopic, Robotic-Assisted, Endoscopic) and end user (Hospitals, Clinics, Home Care, Corporate and Payer Clients).
Who are the key players in the Metabolic Surgery market?
Key players include Medtronic, Johnson & Johnson, Intuitive Surgical, Olympus Corporation and Teleflex Inc.
What is driving the Metabolic Surgery market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the metabolic Surgery market.
How is healthcare paid for in Japan?
Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices). Source: Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.
How many clinical trials on Metabolic Surgery are running in Japan?
12 studies are recruiting, active or about to start in Japan, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Japan. Retrieved 12 Nov 2026.
What does WHO report for Japan?
Obesity (adults): 5.9% of adults in 2024, the latest WHO figure. Source: WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 22 Nov 2026.
How many people in Japan are 65 or older?
30.0% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 22 Nov 2026.
How much research is published on Metabolic Surgery?
PubMed lists 1,452 papers on Metabolic Surgery added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Healthcare Services reports in Japan

See all

Related on obesity and diabetes

See the topic